We are live on
!
Find out more
ACM
Ayer Capital Management Portfolio holdings
AUM
$26.8M
This Fund
S&P 500
This Quarter
Est. Return
+36.53%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$68.3M
AUM Growth
–
Cap. Flow
+$63.5M
Cap. Flow
% of AUM
93.05%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
2
New
2
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Iovance Biotherapeutics
IOVA
|
+$63.1M |
| 2 |
CASC
Cascadian Therapeutics, Inc.
CASC
|
+$409K |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
OHCM
AC
IT
WA
MCM
ADICC
SC
3NC
Ayer Capital Management's Q1 2015 Portfolio in Review
Q1 2015 is the first quarter with a 13F filing on record for Ayer Capital Management, which disclosed 2 positions worth $68.3M. Its ten largest holdings account for 100% of the portfolio.
Its largest position is Iovance Biotherapeutics: 5,604,015 shares worth $67.9M.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets.
- Ayer Capital Management's largest Q1 2015 buy was Iovance Biotherapeutics: 5,604,015 shares worth $67.9M.
- Ayer Capital Management's ten largest holdings make up 100% of its $68.3M portfolio in Q1 2015.
- Ayer Capital Management disclosed 2 positions in Q1 2015, its first 13F filing on record.
Based on Ayer Capital Management's 13F filing for Q1 2015, filed 20 May 2015.